Use of latrunculin-A, an actin monomer-binding drug.
Ayscough
K
K
Department of Biochemistry, University of Dundee, Scotland.
D000199:Actins / Q000378:metabolism*; D000818:Animals; D019086:Bridged Bicyclo Compounds, Heterocyclic / Q000378:metabolism* / Q000494:pharmacology*; D002460:Cell Line; D003599:Cytoskeleton / Q000378:metabolism; D008387:Marine Toxins / Q000378:metabolism / Q000494:pharmacology; D009154:Mutation; D010590:Phalloidine; D011161:Porifera; D011485:Protein Binding; D012235:Rhodamines; D012441:Saccharomyces cerevisiae / Q000187:drug effects; D012568:Schizosaccharomyces / Q000187:drug effects; D013844:Thiazoles / Q000378:metabolism* / Q000494:pharmacology*; D053778:Thiazolidines
D000199:Actins; D019086:Bridged Bicyclo Compounds, Heterocyclic; D008387:Marine Toxins; D012235:Rhodamines; D013844:Thiazoles; D053778:Thiazolidines; D010590:Phalloidine; C037067:latrunculin A